During 1940s, penicillin, the first commercially available antibiotic, was hailed as a “wonder drug.” Penicillin helped make WWII the first American war where infection was not the major cause of death. But by the 1950s, antibiotic resistance became widespread. Scientists were engaged in a veritable arms race, constantly modifying and developing new classes of antibiotics […]
In an era of increased globalization, public health and surveillance are playing an increased role in biosecurity. Whether novel pathogens are intentionally created bioweapons or naturally occurring emerging infectious diseases, recognizing the threat is a necessary prerequisite to countering it. This panel brings together representatives from Federal public health agencies, industry researchers, and representatives of NGO’s.